42 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
be difficult and may take an extended period of time because of the limited number of individuals in Kineta’s industry with the breadth of skills
424B3
dxm1kcvb0yascgo
10 Nov 22
Prospectus supplement
4:21pm
8-K
EX-10.1
wbvbgo dvep
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
CORRESP
zk3kk25 16t
28 Oct 20
Correspondence with SEC
12:00am